D-1029-2020 Class III Terminated
FDA drug recall D-1029-2020 was initiated by Strides Pharma Science Limited on Feb 17, 2020 and is designated Class III. Reason for recall: Failed Tablet/Capsules Specifications: Oversized tablets were found in one lot of Potassium Chloride Tablets 750 mg. The recall status is terminated (terminated Feb 16, 2021). Affected quantity: 2576 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 25, 2020
- Initiation Date
- Feb 17, 2020
- Termination Date
- Feb 16, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2576 bottles
Product description
Potassium Chloride Extended-Release Tablets USP, 10mEq (750mg), 1000-count bottle, Rx only, Manufactured by: Strides Shasun Limited Bengaluru - 562106, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816, NDC 64380-861-08
Reason for recall
Failed Tablet/Capsules Specifications: Oversized tablets were found in one lot of Potassium Chloride Tablets 750 mg.
Distribution pattern
U.S.A. Nationwide
Code information
Lot #: 7238958A, 7238257A, Exp 7/31/2021; 7239404A, Exp 9/30/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1029-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026